| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | parathyroid hormone receptor activity | 1.50e-06 | 2 | 25 | 2 | GO:0004991 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.61e-05 | 140 | 25 | 4 | GO:0001653 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 4.36e-05 | 55 | 25 | 3 | GO:0017046 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 2.27e-04 | 18 | 25 | 2 | GO:0032393 | |
| GeneOntologyMolecularFunction | hormone binding | 2.82e-04 | 103 | 25 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | amide binding | 4.86e-04 | 299 | 25 | 4 | GO:0033218 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 5.97e-04 | 133 | 25 | 3 | GO:0008528 | |
| Domain | HormR | 4.78e-06 | 25 | 25 | 3 | SM00008 | |
| Domain | HRM | 6.79e-06 | 28 | 25 | 3 | PF02793 | |
| Domain | GPCR_2_secretin-like_CS | 1.23e-05 | 34 | 25 | 3 | IPR017983 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 2.03e-05 | 40 | 25 | 3 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 2.03e-05 | 40 | 25 | 3 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 2.03e-05 | 40 | 25 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 3.98e-05 | 50 | 25 | 3 | PS00650 | |
| Domain | 7tm_2 | 3.98e-05 | 50 | 25 | 3 | PF00002 | |
| Domain | GPCR_2-like | 6.89e-05 | 60 | 25 | 3 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 6.89e-05 | 60 | 25 | 3 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 7.24e-05 | 61 | 25 | 3 | PS50261 | |
| Domain | Galactose-bd-like | 6.97e-03 | 94 | 25 | 2 | IPR008979 | |
| Domain | KRAB | 1.18e-02 | 358 | 25 | 3 | PS50805 | |
| Domain | KRAB | 1.18e-02 | 358 | 25 | 3 | PF01352 | |
| Domain | - | 1.19e-02 | 679 | 25 | 4 | 3.30.160.60 | |
| Domain | KRAB | 1.27e-02 | 369 | 25 | 3 | SM00349 | |
| Domain | zf-C2H2 | 1.28e-02 | 693 | 25 | 4 | PF00096 | |
| Domain | KRAB | 1.28e-02 | 370 | 25 | 3 | IPR001909 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.28e-02 | 694 | 25 | 4 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.86e-02 | 775 | 25 | 4 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.87e-02 | 777 | 25 | 4 | PS00028 | |
| Domain | Znf_C2H2-like | 2.03e-02 | 796 | 25 | 4 | IPR015880 | |
| Domain | Znf_C2H2 | 2.11e-02 | 805 | 25 | 4 | IPR007087 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 6.54e-06 | 24 | 22 | 3 | MM15992 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 6.54e-06 | 24 | 22 | 3 | M39643 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 8.31e-05 | 9 | 22 | 2 | M47852 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.07e-04 | 60 | 22 | 3 | MM14964 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 4.03e-04 | 94 | 22 | 3 | M797 | |
| Pubmed | 3.92e-08 | 10 | 25 | 3 | 15670850 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 23524032 | ||
| Pubmed | Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1. | 4.96e-07 | 2 | 25 | 2 | 35192601 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 11098931 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 37647275 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 30365992 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 20131260 | ||
| Pubmed | No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis. | 4.96e-07 | 2 | 25 | 2 | 19874556 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 25112829 | ||
| Pubmed | Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. | 4.96e-07 | 2 | 25 | 2 | 17182560 | |
| Pubmed | Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. | 4.96e-07 | 2 | 25 | 2 | 17694054 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 18539702 | ||
| Pubmed | Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease. | 4.96e-07 | 2 | 25 | 2 | 27708262 | |
| Pubmed | PTH-receptors regulate norepinephrine release in human heart and kidney. | 4.96e-07 | 2 | 25 | 2 | 21756942 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 19008943 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 22896038 | ||
| Pubmed | Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. | 4.96e-07 | 2 | 25 | 2 | 19411600 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 18331531 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 16805919 | ||
| Pubmed | Contribution of functional KIR3DL1 to ankylosing spondylitis. | 4.96e-07 | 2 | 25 | 2 | 20818412 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 19386717 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 19211742 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 28942035 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 20230527 | ||
| Pubmed | Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals. | 1.49e-06 | 3 | 25 | 2 | 12826375 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 19859704 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 24059286 | ||
| Pubmed | Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. | 1.49e-06 | 3 | 25 | 2 | 17301953 | |
| Pubmed | Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. | 1.49e-06 | 3 | 25 | 2 | 19019897 | |
| Pubmed | Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. | 1.49e-06 | 3 | 25 | 2 | 11859120 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 19522772 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 15580659 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 37169313 | ||
| Pubmed | Activating KIR genes are associated with ankylosing spondylitis in Asian populations. | 2.97e-06 | 4 | 25 | 2 | 18638658 | |
| Pubmed | Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. | 2.97e-06 | 4 | 25 | 2 | 27455421 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 18280230 | ||
| Pubmed | Polymorphism and domain variability of human killer cell inhibitory receptors. | 2.97e-06 | 4 | 25 | 2 | 9059894 | |
| Pubmed | Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis. | 4.95e-06 | 5 | 25 | 2 | 16508981 | |
| Pubmed | Killer cell immunoglobulin-like receptor genotypes in Japanese patients with type 1 diabetes. | 4.95e-06 | 5 | 25 | 2 | 17990989 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 20528243 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 9430220 | ||
| Pubmed | HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1. | 1.39e-05 | 8 | 25 | 2 | 27649529 | |
| Pubmed | KIR haplotype content at the allele level in 77 Northern Irish families. | 1.39e-05 | 8 | 25 | 2 | 17200871 | |
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 9430221 | ||
| Pubmed | 1.74e-05 | 70 | 25 | 3 | 12036966 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 1.78e-05 | 9 | 25 | 2 | 8662091 | |
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 18340360 | ||
| Pubmed | 2.22e-05 | 10 | 25 | 2 | 21206914 | ||
| Pubmed | 2.72e-05 | 11 | 25 | 2 | 18830515 | ||
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 2.72e-05 | 11 | 25 | 2 | 19664392 | |
| Pubmed | 3.26e-05 | 12 | 25 | 2 | 20371502 | ||
| Pubmed | 3.26e-05 | 12 | 25 | 2 | 20137308 | ||
| Pubmed | 3.26e-05 | 12 | 25 | 2 | 19936734 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 3.26e-05 | 12 | 25 | 2 | 19181658 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 3.26e-05 | 12 | 25 | 2 | 17490516 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 18687225 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 19934297 | ||
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 19120281 | ||
| Pubmed | 4.49e-05 | 14 | 25 | 2 | 19875891 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | 4.49e-05 | 14 | 25 | 2 | 19421224 | |
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 4.49e-05 | 14 | 25 | 2 | 15896204 | |
| Pubmed | 4.49e-05 | 14 | 25 | 2 | 19489269 | ||
| Pubmed | 4.49e-05 | 14 | 25 | 2 | 18945962 | ||
| Pubmed | 5.18e-05 | 15 | 25 | 2 | 20082646 | ||
| Pubmed | 5.18e-05 | 15 | 25 | 2 | 20643584 | ||
| Pubmed | 5.18e-05 | 15 | 25 | 2 | 19326408 | ||
| Pubmed | 5.18e-05 | 15 | 25 | 2 | 19926642 | ||
| Pubmed | 5.18e-05 | 15 | 25 | 2 | 19850842 | ||
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | 5.18e-05 | 15 | 25 | 2 | 20207982 | |
| Pubmed | 5.18e-05 | 15 | 25 | 2 | 19493232 | ||
| Pubmed | 5.18e-05 | 15 | 25 | 2 | 20356536 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 19897003 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 19279038 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 17868255 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 18643961 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 19309280 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 19000141 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 20670355 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 5.92e-05 | 16 | 25 | 2 | 19527230 | |
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 20331834 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 20652381 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 18668235 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 20210919 | ||
| Pubmed | 6.70e-05 | 17 | 25 | 2 | 19032228 | ||
| Pubmed | 6.70e-05 | 17 | 25 | 2 | 20173792 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 6.70e-05 | 17 | 25 | 2 | 19218127 | |
| Pubmed | 6.70e-05 | 17 | 25 | 2 | 20483367 | ||
| Pubmed | 6.70e-05 | 17 | 25 | 2 | 19968064 | ||
| Pubmed | 6.70e-05 | 17 | 25 | 2 | 19169284 | ||
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 6.70e-05 | 17 | 25 | 2 | 20878400 | |
| Pubmed | 6.70e-05 | 17 | 25 | 2 | 20650299 | ||
| Pubmed | 6.70e-05 | 17 | 25 | 2 | 19450876 | ||
| Pubmed | 6.70e-05 | 17 | 25 | 2 | 19761533 | ||
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 7.54e-05 | 18 | 25 | 2 | 19046302 | |
| Pubmed | 7.54e-05 | 18 | 25 | 2 | 19846535 | ||
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 7.54e-05 | 18 | 25 | 2 | 19630074 | |
| Pubmed | 7.54e-05 | 18 | 25 | 2 | 20519398 | ||
| Pubmed | 7.54e-05 | 18 | 25 | 2 | 20580654 | ||
| Pubmed | 7.54e-05 | 18 | 25 | 2 | 20210918 | ||
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | 8.42e-05 | 19 | 25 | 2 | 18778326 | |
| Cytoband | 19q13.4 | 1.10e-05 | 79 | 25 | 3 | 19q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q14 | 3.65e-03 | 165 | 25 | 2 | chr2q14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 3.70e-03 | 1192 | 25 | 4 | chr19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 1.28e-02 | 316 | 25 | 2 | chr3p21 | |
| GeneFamily | Parathyroid hormone receptors | 1.05e-06 | 2 | 19 | 2 | 270 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 1.58e-04 | 18 | 19 | 2 | 620 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.94e-03 | 718 | 19 | 4 | 28 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.94e-02 | 206 | 19 | 2 | 682 | |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | 6.10e-05 | 423 | 22 | 5 | GSM399454_500 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.46e-07 | 101 | 24 | 4 | 86acaa2502f61baa714ae988b73e3e73a71e897e | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.77e-05 | 162 | 24 | 3 | 59f6a9005c4f22f084c25ea36f3cacce5144a9ae | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.26e-05 | 165 | 24 | 3 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.43e-05 | 166 | 24 | 3 | a42268a02a89fc97272e45c4cbe21acf04b7428c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 172 | 24 | 3 | 2ab720a4c96073339a1f8b95ec7699682df98acf | |
| ToppCell | 11.5-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 1.07e-04 | 173 | 24 | 3 | 6989c9cebcd81eccceac7e5a86152676ee959386 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 176 | 24 | 3 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 177 | 24 | 3 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 178 | 24 | 3 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 178 | 24 | 3 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.16e-04 | 178 | 24 | 3 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 180 | 24 | 3 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 180 | 24 | 3 | 1c5515f29ead129bee3b4ca27799796956811a39 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Brain / Location, Cell class and cell subclass | 1.20e-04 | 180 | 24 | 3 | 51727cb66fe7a7709453f7026e0ff3d6c93d5aa5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 181 | 24 | 3 | 338c7362d258a87f1a6b1a65376f5394d4b2b4b2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 182 | 24 | 3 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-Late_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 182 | 24 | 3 | f8257c884393f168f605d371e0840cfca8d3657e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 184 | 24 | 3 | ca35a3d2b536c8b2bf5c4d635605e5a3ae94a428 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.30e-04 | 185 | 24 | 3 | 492529121cb9e88bd3c0db6b54af3cd2979572bc | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.32e-04 | 186 | 24 | 3 | 294839944266407c40ef86e1d3e0fce4652b70ff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_EGR3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 186 | 24 | 3 | 77b09af860183606a1775eba921e2071e4a7dd4e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 189 | 24 | 3 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 189 | 24 | 3 | aba941ba6ce7702418b3f470bde573d123c4aade | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 189 | 24 | 3 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.43e-04 | 191 | 24 | 3 | 14b11244c330cc4fe897253aaaf0df80caa01a55 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.43e-04 | 191 | 24 | 3 | b5374674312ff5803a1d369f5533027532344679 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 192 | 24 | 3 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 192 | 24 | 3 | e0412964a3ee1bf3c0ef64f9a6f20f7e7835701e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 192 | 24 | 3 | 690cf19e9b0b2ada80097c63eae827529aa5b6f3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 192 | 24 | 3 | b5871247a5f3e970fa05b33fff21bef9d2ab5741 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 192 | 24 | 3 | 3d6c4c5847ca1e44fa380403d25af45d5b51ee9b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 193 | 24 | 3 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 193 | 24 | 3 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-04 | 193 | 24 | 3 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 195 | 24 | 3 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.52e-04 | 195 | 24 | 3 | 9016a44b521214546a55a822ebdef5b5312206d2 | |
| ToppCell | Primary_Visual_cortex_(V1C)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 195 | 24 | 3 | 24dbb125565facd2de42d848471d4867c81acf80 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 195 | 24 | 3 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 200 | 24 | 3 | 55b7b17f2d413b9ebb262ef8bd210ef45618a7f3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 200 | 24 | 3 | 741e59c68ae4a3a7be830e98771a14f920c9e883 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-04 | 71 | 24 | 2 | 5d63a582229520b2a037f3c27f772e34cdee092b | |
| ToppCell | mild-immature_Neutrophil|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.04e-04 | 83 | 24 | 2 | f7225bc24ad6df3a41375cc4614af824e0db3559 | |
| ToppCell | mild-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.55e-03 | 109 | 24 | 2 | 2f03d6ee8b13424cc6a5bc60ac3461b44dff9d79 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-03 | 116 | 24 | 2 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-03 | 118 | 24 | 2 | 8d96a4879b28979fa04fbaeffa271a6b9ecbe867 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P1-P1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.84e-03 | 119 | 24 | 2 | 0dd72dbded7ade911612d20e0c6e3f40e85fc890 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.84e-03 | 119 | 24 | 2 | 0c9aff5442a1b1e51e142d6527d5a48211d94335 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.84e-03 | 119 | 24 | 2 | 7367b6e4906d234ca864075443efe420ee407421 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.87e-03 | 120 | 24 | 2 | 2b7596946f9268c4202348adf3069decd8313bb0 | |
| ToppCell | |World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-03 | 121 | 24 | 2 | da8fe561dcf50792d0cbcaad383d564f900a6677 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Th_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.06e-03 | 126 | 24 | 2 | 3a14d4eb8803827946c36faeeb7ae2913418d421 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.09e-03 | 127 | 24 | 2 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | severe-unassigned|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.13e-03 | 128 | 24 | 2 | bef9cf0078fa8498d63f0723f1fa4a3c92405e10 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.23e-03 | 131 | 24 | 2 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.26e-03 | 132 | 24 | 2 | 66ec5a06eece27c0aafb548f51db9fee595e71bc | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-03 | 133 | 24 | 2 | 81189e8516a431d5890a0909f9fc7c82ec3442bc | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.33e-03 | 134 | 24 | 2 | 1d6e74612fd91a2ef9d14bf77262b2d08e1052ca | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-03 | 136 | 24 | 2 | 82d7f90ef2a63a3137c331efd68c036cd0db3ac1 | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.54e-03 | 140 | 24 | 2 | 2c04fa782aa076e4be8a2781aa04231180bd69bd | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.54e-03 | 140 | 24 | 2 | 17005ca714ba03d7528fe7979ffb4654a46b666c | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia.C1qb.Tmem119-Fos)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.54e-03 | 140 | 24 | 2 | a9389a6e55d02d5037868c9ecce48b5e8d7c2902 | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.54e-03 | 140 | 24 | 2 | 8db98a17a4d4b42dbfc75e9cdaa22275fed4f2f0 | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia.C1qb.Tmem119-Fos)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.54e-03 | 140 | 24 | 2 | 22098203361f61b9f0ce9f0f2d1369d8bb1379a8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.57e-03 | 141 | 24 | 2 | 5ef3166c5271aa90fd0633016edfe2c74b835319 | |
| ToppCell | Control-Hematopoietic_Mast-Mast_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-03 | 142 | 24 | 2 | a81f7ea4516a869c7c9b9a3f4ef74844ff9fffcd | |
| ToppCell | Control-Hematopoietic_Mast-Mast_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-03 | 142 | 24 | 2 | 70f8c1be134835e0d21e6d426b7122f0f5d3d3e5 | |
| ToppCell | PBMC-Mild-cDC_7|Mild / Compartment, Disease Groups and Clusters | 2.61e-03 | 142 | 24 | 2 | 58f66f35646f281e64d634e6c26adbd1d4e6c830 | |
| ToppCell | Control-Hematopoietic_Mast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-03 | 142 | 24 | 2 | db9b7acbab730ae391a362f1ca8177507e52250d | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 2.61e-03 | 142 | 24 | 2 | 1175d4390d204ffa3a2d2fe24486f85d3b639b72 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-03 | 143 | 24 | 2 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | P03-Hematopoietic-Erythroid-enucleate_erythrocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-03 | 144 | 24 | 2 | 9fa63904389f4d7163db22ea85ab721d8f6e8d99 | |
| ToppCell | P07-Hematopoietic-Immune-immune_cell_unspecified|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-03 | 144 | 24 | 2 | eb057dbdb2a5a2d29b93e5ed5479a3fd1bf3fd26 | |
| ToppCell | P03-Hematopoietic-Erythroid|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-03 | 144 | 24 | 2 | 2ee6a834860eac7ed004f366ab4fc38c4b80c905 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-03 | 144 | 24 | 2 | 013223bb2f31eb5bebdbd0908b797d28b96c6f7b | |
| ToppCell | P07-Hematopoietic-Immune|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-03 | 144 | 24 | 2 | 962698c5c15bd583fccda0593b7aab5f2eb4bc9f | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.72e-03 | 145 | 24 | 2 | dc89d817a9bef24a07e992efdab4136f12ceb399 | |
| ToppCell | COVID-19-Mast_cells-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 2.72e-03 | 145 | 24 | 2 | 5c5fed4620c4c312d1052b8acad910453f7e8fcc | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.75e-03 | 146 | 24 | 2 | 03a6a442f1f6d173a41aeebbfe41ee08853d9585 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.75e-03 | 146 | 24 | 2 | 10839a4fce2e62955a90592f927a6e0c6a84bbad | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.87e-03 | 149 | 24 | 2 | 406a5ccfedbf43543f0346ff7ef3ce1d15c38f29 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.87e-03 | 149 | 24 | 2 | 34a3075af794052763fc7c4135f3031f89da5caa | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.87e-03 | 149 | 24 | 2 | be698ecce34ddbdf57d08082b71268934675e74e | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.87e-03 | 149 | 24 | 2 | 183c77cc8f23b8406e7241a066cb684470002a3b | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.90e-03 | 150 | 24 | 2 | 6d65df8c0937b498585d1e79919ec73daa354e21 | |
| ToppCell | TCGA-Kidney|World / Sample_Type by Project: Shred V9 | 2.94e-03 | 151 | 24 | 2 | e31974c0d0a0c644205a0ee6013ab74a09d8a306 | |
| ToppCell | Hippocampus-Hematopoietic|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.94e-03 | 151 | 24 | 2 | 81b2189afd72658f7e2539b856ba79cd49340215 | |
| ToppCell | 368C-Myeloid-Mast_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-03 | 152 | 24 | 2 | faf30245a1690aaa27c7be0832797c340e4af4d7 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Mast_cell-Mast_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.98e-03 | 152 | 24 | 2 | 321d322d58c12fd752de4e8ea873f3f367302813 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Mast_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.98e-03 | 152 | 24 | 2 | a4d50e9af02231c5573aee905cf0905391e6da34 | |
| ToppCell | 368C-Myeloid-Mast_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-03 | 152 | 24 | 2 | 519c9ed05fdaf420e42147ffae1dc05a7f86fdd4 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-03 | 153 | 24 | 2 | 3b1b0cc8e9dd2b1484649789330713282ee44414 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-03 | 154 | 24 | 2 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-03 | 155 | 24 | 2 | 98d8432739965dd1ab77c899cb6321f7f05eaa46 | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 3.14e-03 | 156 | 24 | 2 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-03 | 156 | 24 | 2 | 55ba43cec9d79f309e9f633a6469cf03bb621e64 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 3.14e-03 | 156 | 24 | 2 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.14e-03 | 156 | 24 | 2 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.14e-03 | 156 | 24 | 2 | c380142e49b1e4ecacbf37587aafa57f8562b6ad | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue | 3.14e-03 | 156 | 24 | 2 | 0ea6ca3f38109151a2a4fdf63a4f009929cdcc40 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.14e-03 | 156 | 24 | 2 | 17c38d3b03fc38cb125cf0d165b2fd694cd88edd | |
| Drug | iodine atom | 1.12e-06 | 19 | 25 | 3 | CID005360629 | |
| Drug | bp 16 | 1.16e-05 | 5 | 25 | 2 | CID000127325 | |
| Drug | benzophenone | 1.84e-05 | 47 | 25 | 3 | CID000003102 | |
| Drug | Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 5.51e-05 | 193 | 25 | 4 | 948_UP | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 5.62e-05 | 194 | 25 | 4 | 7354_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; PC3; HT_HG-U133A | 5.73e-05 | 195 | 25 | 4 | 4644_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.73e-05 | 195 | 25 | 4 | 3315_DN | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; PC3; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 4321_UP | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 2638_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Up 200; 17uM; PC3; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 3802_UP | |
| Drug | Bisoprolol fumarate; Up 200; 9uM; PC3; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 6748_UP | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; HL60; HT_HG-U133A | 6.32e-05 | 200 | 25 | 4 | 1278_DN | |
| Disease | malaria (is_implicated_in) | 1.19e-04 | 24 | 20 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | tuberculosis (is_implicated_in) | 1.63e-04 | 28 | 20 | 2 | DOID:399 (is_implicated_in) | |
| Disease | hepatitis C (is_implicated_in) | 1.63e-04 | 28 | 20 | 2 | DOID:1883 (is_implicated_in) | |
| Disease | human immunodeficiency virus infectious disease (is_implicated_in) | 3.19e-04 | 39 | 20 | 2 | DOID:526 (is_implicated_in) | |
| Disease | Disproportionate short stature | 1.24e-03 | 77 | 20 | 2 | C0878659 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CFYIHAKMRQEHRNR | 361 | P26196 | |
| CLLNYLREMRHRFQT | 481 | Q06187 | |
| HMFRLCYRVLRHSQE | 551 | Q14573 | |
| LAARAMRNNFRHYFI | 391 | Q6ZWT7 | |
| TLRCHYRHRFNNFML | 46 | P43629 | |
| LCRHTRLFYMVRAQA | 981 | Q14999 | |
| QYRNRIAMEFNHLYH | 371 | P23219 | |
| HARRCRFNMELYRLS | 316 | O00634 | |
| LAYLMHHFGVRHRFC | 71 | Q96NT3 | |
| SRHRLFLTYRHCRNF | 91 | Q9C0J1 | |
| VHRRVCNRFHAFLLY | 946 | Q9Y613 | |
| YFMFAVRCRHQRRQL | 256 | Q9NZT2 | |
| RHTHQLYNFLRFCEM | 126 | Q8WV92 | |
| TLRCHYRHRFNNFML | 46 | Q14943 | |
| ERILYQFSRRFHHCN | 656 | Q8NDX1 | |
| HYRFCCEHRHMRLAQ | 111 | A6NL88 | |
| AGRMLRFSVFYRNHH | 131 | Q92561 | |
| CHRNVFRYLMAFLRE | 831 | Q01968 | |
| CTYCRRHFMSAFHLR | 716 | Q13129 | |
| YFRRLHCTRNYIHMH | 211 | Q03431 | |
| AFRRLHCTRNYIHMH | 166 | P47872 | |
| EMAFRYHYQLIEHCR | 311 | Q9Y6R6 | |
| RLHCTRNYIHMHLFV | 171 | P49190 | |
| EIFRLHFRQLCYHEM | 51 | Q9P0L1 | |
| FRYCFTLNRHQRVHS | 451 | P17021 |